RxDoctor Payments Data

Matthew D Alessio, MD

Surgical Oncology · Delray Beach, FLNPI 1104913532

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (29.1%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Medtronic at 50.8% of the total. 2025 is the largest year on record at $10,470, more than ten times the $96 reported in 2019.

$24,088in general payments, 2019–2025

Across 82 payments — averaging $293.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$12K
  • Intuitive Surgical$9K
  • Histosonics, Inc.$650
  • Kerecis Limited$417
  • Integra Lifesciences Corporation$405
  • Davol Inc.$272
  • plus $1K from 15 others

What the payments were for

  • Consulting fees$3,83016%
  • Speaking & faculty fees$6,93929%
  • Travel & lodging$1,9628%
  • Food & beverage$4,35618%
  • Education$7,00029%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,088 in reported general payments places this provider in the 85th percentile of 133 surgical oncology providers in Florida.

See all surgical oncology providers in Florida

Medicare billing

Part B allowed, 2024
$327,329
Medicare patients
205
Services billed
797

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen54$272
Neomycin Sulfate34$174
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen22$95
Metronidazole36$63
Ondansetron Hcl15$62

Paid to pharmacies, not to this prescriber.

Other surgical oncology in Delray Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →